UI Investissement focuses on financing and supporting unlisted French startups, SMEs, and mid-sized companies across three main segments: Capital Développement & Transmission, Capital Innovation, and Consolidation. Their strategy involves providing financial and operational expertise, with a sectoral focus on Healthcare, Agro-business, and Services & Industry.
43% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (71% of deals). Average disclosed round size is $20.1M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
$1.5B
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| EExeliom Biosciences | Series A | $2.9M | Oct 2025 |
| FFungu'it | Seed | $4M | Jun 2025 |
 Coave Therapeutics | Series A | $33M | Jan 2025 |
| OOverseed Biotech | Series A | $6.7M | Jul 2024 |
 Latitude | Series B | $30M | Jan 2024 |
| MMecaware | Series A | $40M | Oct 2023 |
| EExeliom Biosciences | Series A | $24M | Jul 2023 |
Top Co-Investors
Crescent1 shared
EIT InnoEnergy1 shared
Bpifrance1 shared
Invus1 shared
Fund+1 shared
Kurma Partners1 shared
Omnes Capital1 shared
Blast.Club1 shared
Kima Ventures1 shared
Last updated: 8 March 2026